Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

472 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment Discontinuation Impact on Long-Term (10-Year) Weight Gain and Lipid Metabolism in First-Episode Psychosis: Results From the PAFIP-10 Cohort.
Vázquez-Bourgon J, Mayoral-van Son J, Gómez-Revuelta M, Juncal-Ruiz M, Ortiz-García de la Foz V, Tordesillas-Gutiérrez D, Ayesa-Arriola R, Bioque M, Crespo-Facorro B. Vázquez-Bourgon J, et al. Int J Neuropsychopharmacol. 2021 Jan 20;24(1):1-7. doi: 10.1093/ijnp/pyaa066. Int J Neuropsychopharmacol. 2021. PMID: 32840607 Free PMC article.
Reduced thalamic volume in first-episode non-affective psychosis: correlations with clinical variables, symptomatology and cognitive functioning.
Crespo-Facorro B, Roiz-Santiáñez R, Pelayo-Terán JM, Rodríguez-Sánchez JM, Pérez-Iglesias R, González-Blanch C, Tordesillas-Gutiérrez D, González-Mandly A, Díez C, Magnotta VA, Andreasen NC, Vázquez-Barquero JL. Crespo-Facorro B, et al. Neuroimage. 2007 May 1;35(4):1613-23. doi: 10.1016/j.neuroimage.2007.01.048. Epub 2007 Feb 13. Neuroimage. 2007. PMID: 17395492
A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.
Perez-Iglesias R, Crespo-Facorro B, Amado JA, Garcia-Unzueta MT, Ramirez-Bonilla ML, Gonzalez-Blanch C, Martinez-Garcia O, Vazquez-Barquero JL. Perez-Iglesias R, et al. J Clin Psychiatry. 2007 Nov;68(11):1733-40. doi: 10.4088/jcp.v68n1113. J Clin Psychiatry. 2007. PMID: 18052567 Clinical Trial.
Weight gain induced by haloperidol, risperidone and olanzapine after 1 year: findings of a randomized clinical trial in a drug-naïve population.
Perez-Iglesias R, Crespo-Facorro B, Martinez-Garcia O, Ramirez-Bonilla ML, Alvarez-Jimenez M, Pelayo-Teran JM, Garcia-Unzueta MT, Amado JA, Vazquez-Barquero JL. Perez-Iglesias R, et al. Schizophr Res. 2008 Feb;99(1-3):13-22. doi: 10.1016/j.schres.2007.10.022. Epub 2007 Dec 3. Schizophr Res. 2008. PMID: 18053689 Clinical Trial.
1-year follow-up study of cognitive function in first-episode non-affective psychosis.
Rodríguez-Sánchez JM, Pérez-Iglesias R, González-Blanch C, Pelayo-Terán JM, Mata I, Martínez O, Sánchez-Cubillo I, Vázquez-Barquero JL, Crespo-Facorro B. Rodríguez-Sánchez JM, et al. Schizophr Res. 2008 Sep;104(1-3):165-74. doi: 10.1016/j.schres.2008.05.020. Epub 2008 Jul 16. Schizophr Res. 2008. PMID: 18635340
472 results